These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 10833509

  • 1. The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function.
    Thirunavukkarasu K, Halladay DL, Miles RR, Yang X, Galvin RJ, Chandrasekhar S, Martin TJ, Onyia JE.
    J Biol Chem; 2000 Aug 18; 275(33):25163-72. PubMed ID: 10833509
    [Abstract] [Full Text] [Related]

  • 2. Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-beta (TGF-beta). Mapping of the OPG promoter region that mediates TGF-beta effects.
    Thirunavukkarasu K, Miles RR, Halladay DL, Yang X, Galvin RJ, Chandrasekhar S, Martin TJ, Onyia JE.
    J Biol Chem; 2001 Sep 28; 276(39):36241-50. PubMed ID: 11451955
    [Abstract] [Full Text] [Related]

  • 3. High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage.
    Geoffroy V, Kneissel M, Fournier B, Boyde A, Matthias P.
    Mol Cell Biol; 2002 Sep 28; 22(17):6222-33. PubMed ID: 12167715
    [Abstract] [Full Text] [Related]

  • 4. Runx-2 is not essential for the vitamin D-regulated expression of RANKL and osteoprotegerin in osteoblastic cells.
    Notoya M, Otsuka E, Yamaguchi A, Hagiwara H.
    Biochem Biophys Res Commun; 2004 Nov 12; 324(2):655-60. PubMed ID: 15474477
    [Abstract] [Full Text] [Related]

  • 5. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ, Wronski TJ, Iwaniec U, Phleger L, Kurimoto P, Boudignon B, Halloran BP.
    J Bone Miner Res; 2005 Sep 12; 20(9):1659-68. PubMed ID: 16059637
    [Abstract] [Full Text] [Related]

  • 6. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption.
    Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL.
    J Bone Miner Res; 2000 Jan 12; 15(1):2-12. PubMed ID: 10646108
    [Abstract] [Full Text] [Related]

  • 7. Cbfa1 does not regulate RANKL gene activity in stromal/osteoblastic cells.
    O'Brien CA, Kern B, Gubrij I, Karsenty G, Manolagas SC.
    Bone; 2002 Mar 12; 30(3):453-62. PubMed ID: 11882458
    [Abstract] [Full Text] [Related]

  • 8. Functional role for heat shock factors in the transcriptional regulation of human RANK ligand gene expression in stromal/osteoblast cells.
    Roccisana JL, Kawanabe N, Kajiya H, Koide M, Roodman GD, Reddy SV.
    J Biol Chem; 2004 Mar 12; 279(11):10500-7. PubMed ID: 14699143
    [Abstract] [Full Text] [Related]

  • 9. Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF).
    Gao YH, Shinki T, Yuasa T, Kataoka-Enomoto H, Komori T, Suda T, Yamaguchi A.
    Biochem Biophys Res Commun; 1998 Nov 27; 252(3):697-702. PubMed ID: 9837769
    [Abstract] [Full Text] [Related]

  • 10. EBF2 regulates osteoblast-dependent differentiation of osteoclasts.
    Kieslinger M, Folberth S, Dobreva G, Dorn T, Croci L, Erben R, Consalez GG, Grosschedl R.
    Dev Cell; 2005 Dec 27; 9(6):757-67. PubMed ID: 16326388
    [Abstract] [Full Text] [Related]

  • 11. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
    Udagawa N, Takahashi N, Yasuda H, Mizuno A, Itoh K, Ueno Y, Shinki T, Gillespie MT, Martin TJ, Higashio K, Suda T.
    Endocrinology; 2000 Sep 27; 141(9):3478-84. PubMed ID: 10965921
    [Abstract] [Full Text] [Related]

  • 12. Induction of osteoclast differentiation by Runx2 through receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin regulation and partial rescue of osteoclastogenesis in Runx2-/- mice by RANKL transgene.
    Enomoto H, Shiojiri S, Hoshi K, Furuichi T, Fukuyama R, Yoshida CA, Kanatani N, Nakamura R, Mizuno A, Zanma A, Yano K, Yasuda H, Higashio K, Takada K, Komori T.
    J Biol Chem; 2003 Jun 27; 278(26):23971-7. PubMed ID: 12697767
    [Abstract] [Full Text] [Related]

  • 13. The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated.
    Gori F, Hofbauer LC, Dunstan CR, Spelsberg TC, Khosla S, Riggs BL.
    Endocrinology; 2000 Dec 27; 141(12):4768-76. PubMed ID: 11108292
    [Abstract] [Full Text] [Related]

  • 14. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
    Kwon OH, Lee CK, Lee YI, Paik SG, Lee HJ.
    Biochem Biophys Res Commun; 2005 Sep 23; 335(2):437-46. PubMed ID: 16083856
    [Abstract] [Full Text] [Related]

  • 15. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H, Härkönen PL, Väänänen HK, Hentunen TA.
    J Bone Miner Res; 2005 Dec 23; 20(12):2224-32. PubMed ID: 16294275
    [Abstract] [Full Text] [Related]

  • 16. A novel molecular mechanism modulating osteoclast differentiation and function.
    Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Goto M, Mochizuki SI, Tsuda E, Morinaga T, Udagawa N, Takahashi N, Suda T, Higashio K.
    Bone; 1999 Jul 23; 25(1):109-13. PubMed ID: 10423033
    [Abstract] [Full Text] [Related]

  • 17. Microrough implant surface topographies increase osteogenesis by reducing osteoclast formation and activity.
    Lossdörfer S, Schwartz Z, Wang L, Lohmann CH, Turner JD, Wieland M, Cochran DL, Boyan BD.
    J Biomed Mater Res A; 2004 Sep 01; 70(3):361-9. PubMed ID: 15293309
    [Abstract] [Full Text] [Related]

  • 18. Regulatory mechanisms of osteoblast and osteoclast differentiation.
    Katagiri T, Takahashi N.
    Oral Dis; 2002 May 01; 8(3):147-59. PubMed ID: 12108759
    [Abstract] [Full Text] [Related]

  • 19. Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation.
    Lee SK, Lorenzo JA.
    Endocrinology; 1999 Aug 01; 140(8):3552-61. PubMed ID: 10433211
    [Abstract] [Full Text] [Related]

  • 20. Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis.
    Grimaud E, Soubigou L, Couillaud S, Coipeau P, Moreau A, Passuti N, Gouin F, Redini F, Heymann D.
    Am J Pathol; 2003 Nov 01; 163(5):2021-31. PubMed ID: 14578201
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.